// App-Quantinova.ai

640 : Elevated Serum Interleukin-23 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity, Clinical and Immunological Markers

Researchers

Presenter

  • Anita Laloo

Principal Investigators

  • Vasileios Kyttaris

Medical Centers

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Rheumatology Practice, Fort Lauderdale, FL

  • Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • Interleukin-23

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Oraprine

  • Tocilizumab

  • Interleukin

  • Prednisone

  • Tacrolimus

  • Belimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved